Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says
Compared to Lilly’s Zepbound (tirzepatide), the once-daily experimental drug would be simpler to produce.
Business
Japan’s loneliness epidemic is so bad that elderly women are committing crimes to find friends and health care in prison
Japan’s largest women’s prison has become home to a growing number of seniors.
LVMH’s Olympic medals are already rusting and more than 100 top athletes want replacements
LVMH washed its hands of the faux pas, claiming this week that Chaumet merely designed the medals.
ZETA DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Zeta Global Holdings Corp. Investors to Secure Counsel Before Important January 21 Deadline in Securities Class Action – ZETA
New York, New York–(Newsfile Corp. – January 21, 2025) – WHY: Rosen Law Firm, a...
Dollar rebounds and stocks climb with all eyes on Trump 2.0
By Harry Robertson and Koh Gui Qing NEW YORK/LONDON (Reuters) – World stocks rose on...
XRAY DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Dentsply Sirona Inc. Investors to Secure Counsel Before Important January 27 Deadline in Securities Class Action – XRAY
New York, New York–(Newsfile Corp. – January 21, 2025) – WHY: Rosen Law Firm, a...
Fondul Proprietatea advances AIFM selection process
BUCHAREST – Fondul Proprietatea S.A., a Romanian investment fund, has announced progress in its search...
Cambridge Cognition launches rater training service
LONDON – Cambridge Cognition Holdings (LON:) PLC (AIM: COG), a developer of digital brain health...
Bono Energy ups stake in Nostra Terra to 3.38%
LONDON – Nostra Terra Oil and Gas Company Plc, an international oil and gas exploration...
